Latest: FDA Approves New Biosimilar for Oncology Treatment

CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges

Publication Article Supplements and Featured Publications This supplement was sponsored by Johnson & Johnson and Legend Biotech. In this AJMC® Roundtable discussion, healthcare decision makers examined barriers to timely access to CAR-T cell therapy and identified solutions to streamline approval processes and enhance payer education for improved patient care. Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics. 259 Prospect Plains Rd, Bldg H, Monroe, NJ 08831 © 2025 MJH Life Sciences® and AJMC®. All rights reserved.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago